I Introduction
RF ablation has been successfully utilized as a minimally invasive treatment for primary and metastatic liver tumors, as well as tumors in kidney, lung, bone, and adrenal gland tissue [1]–[6]. Since the introduction of RF ablation for tumor treatment, the inability to create large ablation zone volumes without multiple power applications has been a major limitation. While current commercial systems have allowed the creation of larger coagulation zones (4–6 cm) than initial systems (1.5 cm), partially due to an increase in maximum generator power (250 versus 50 W), recent studies have shown the possibility of obtaining even larger coagulation zones by using higher power levels (up to 1000 W) [7], [8]. However, it should be noted that not all applicators, currently in clinical use, will benefit from higher power, and new applicators may be required to take advantage of higher power levels.